Press Releases
Axial Biotech Announces Mike McCaffrey, Distinguished Orthopeadic Executive, Joins Board of Directors
SALT LAKE CITY, UTAH, (October 5, 2005) — Axial Biotech is proud to announce that Mike McCaffrey, former Chairman of DePuy Spine, is joining its Board of Directors. Axial Biotech is revolutionizing spine care by developing molecular diagnostics and motion preserving technologies. Mr. McCaffrey joins Axial at an exciting time as the Company is making significant progress on its first product: a molecular diagnostic test for adolescent idiopathic scoliosis.
Mr. McCaffrey's impressive orthopaedic industry career has spanned more than two decades. Mr. McCaffrey was instrumental in the development and expansion of four of DePuy's five operating companies and at varying times was responsible for the management of DePuy, Inc., DePuy Spine, DePuy Trauma and DePuy Development Corporation. He brings a depth of experience from his distinguished career in medical technology as an individual that worked with leading clinicians and researchers to develop and market innovative solutions for orthopaedics and spine.
During his fifteen-year career at Depuy, Mr. McCaffrey started and later became Chairman of Depuy Spine, one of the fastest growing companies in the medical device and diagnostics sector. Under Mr. McCaffrey's leadership, DePuy Spine became known throughout the medical world for its development of novel products to treat a wide range of spine disorders and for advancing the knowledge of spinal pathologies for patients and professionals alike. Highly respected in the orthopaedic industry, Mr. McCaffrey was the first layman to be elected to the Board of Directors of the Orthopaedic Research and Education Foundation. "After helping found one of the largest spine companies in the world, I am thrilled to be involved with Axial Biotech. Their first product has the potential to completely change the way we diagnose and treat scoliosis, and that is very exciting. I think they are one of the most innovative companies in the spine market today," said Mr. McCaffrey. Equally enthused with the addition of Mr. McCaffrey to the Axial Board, Axial Founder, President and CEO, John M. Climaco, said: "As we enter our next stage of development and look forward to commercializing our first product, having a true industry leader like Mike McCaffrey on our board is invaluable."
About Axial Biotech
Axial Biotech, Inc. is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. The company is focused on developing and commercializing DNA-based pre-symptomatic and prognostic tests, as well as motion-preserving technologies, for common spinal disorders. The company's headquarters and laboratory are located in Salt Lake City, Utah
Media Contact:
Eric K. Olson
Executive Vice President Sales and Marketing
Axial Biotech, Inc.
801-984-9100 ext. 129
eolson@axialbiotech.com
